SITC Archive Library

Available here is the Society for Immunotherapy of Cancer (SITC) 2017 Accomplishments Report.

SITC is the world’s leading member-driven organization specifically dedicated to professionals working in the field of cancer immunology and immunotherapy. A 501(c)(3) not-for-profit organization, SITC was established in 1984 to exchange, encourage and promote information about the promise of immunotherapy for patients with cancer.

2017 was a record-setting year, confirming SITC as the leader in the cancer immunotherapy field. Using the 2016-2018 Strategic Plan as the framework, SITC has made incredible strides to help position cancer immunotherapy as a valuable treatment modality in the fight against cancer.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#SITC#2017#Document#SITCPublication